Correlation Between Kiniksa Pharmaceuticals and Celldex Therapeutics

Can any of the company-specific risk be diversified away by investing in both Kiniksa Pharmaceuticals and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiniksa Pharmaceuticals and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kiniksa Pharmaceuticals and Celldex Therapeutics, you can compare the effects of market volatilities on Kiniksa Pharmaceuticals and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiniksa Pharmaceuticals with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiniksa Pharmaceuticals and Celldex Therapeutics.

Diversification Opportunities for Kiniksa Pharmaceuticals and Celldex Therapeutics

0.55

Correlation Coefficient

Kiniksa Pharmaceuticals  Celldex Therapeutics

Very weak diversification

The 3 months correlation between Kiniksa and Celldex is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Kiniksa Pharmaceuticals and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and Kiniksa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiniksa Pharmaceuticals are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of Kiniksa Pharmaceuticals i.e., Kiniksa Pharmaceuticals and Celldex Therapeutics go up and down completely randomly.

Pair Corralation between Kiniksa Pharmaceuticals and Celldex Therapeutics

Given the investment horizon of 90 days Kiniksa Pharmaceuticals is expected to generate 0.78 times more return on investment than Celldex Therapeutics. However, Kiniksa Pharmaceuticals is 1.28 times less risky than Celldex Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Celldex Therapeutics is currently generating about -0.18 per unit of risk. If you would invest  2,462  in Kiniksa Pharmaceuticals on September 23, 2024 and sell it today you would lose (403.00) from holding Kiniksa Pharmaceuticals or give up 16.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Kiniksa Pharmaceuticals  vs.  Celldex Therapeutics

Kiniksa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kiniksa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Celldex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celldex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Kiniksa Pharmaceuticals and Celldex Therapeutics

The main advantage of trading using opposite Kiniksa Pharmaceuticals and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiniksa Pharmaceuticals position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.

The idea behind Kiniksa Pharmaceuticals and Celldex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.